­
­
­
­

Inventi Impact: Preventive & Social Medicines

Articles

  • Inventi:hpsm/30564/19
    Global Cardiovascular Risk of the HIV Positive Patients Receiving Antiretroviral Therapy in Brazzaville
    Research 2020 : January - March
    Stephane Meo Ikama, Franck Ekoba-Otende, Jospin Makani, Amelia Bokilo, Bienvenu Ossibi-Ibara, Louis Igor Ondze-Kafata, Bertrand Fikhaem Ellenga-Mbolla, Thierry Raoul Gombet, Suzy Gisele Kimbally-Kaky

    A cross-sectional, descriptive and analytical study was conducted from January\nto August 2015 at the Brazzaville Ambulatory Treatment Center and at\nthe National Blood Transfusion Center. The objective was to contribute to improving\nthe care of people living with HIV under antiretroviral therapy by assessing\ntheir global cardiovascular risk (CVR). The variables studied focused on\nthe epidemiological, clinical and biological aspects. The global CVR was assessed\nby the Framingham and WHO/ISH scores. There were 135 HIV-positive subjects,\nincluding 64 treated patients and 71 untreated HIV+ subjects. The subjects\nwere divided into 83 men (61.5%) and 52 women (38.5%), with an average\nage of������.

    How to Cite this Article
    Attribution/ CC Compliant Citation: Ikama, S.M., Ekoba- Otende, F., Makani, J., Bokilo, A., Ossibi-Ibara, B., Ondze-Kafata, L.I.,\nEllenga-Mbolla, B.F., Gombet, T.R. and Kimbally- Kaky, S.G. (2019) Global Cardiovascular Risk of the HIV Positive Patients\nReceiving Antiretroviral Therapy in Brazzaville. World Journal of Cardiovascular Diseases, 9, 553-561.\nhttps://doi.org/10.4236/wjcd.2019.98048\nhttp://creativecommons.org/licenses/by/4.0/\n\nSome formatting elements, header, footer, logos, dates and pagination were modified while adapting this article.
    Download Full Text